chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itching; hives; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching) and URTICARIA (hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching) and URTICARIA (hives). At the time of the report, PRURITUS (itching) and URTICARIA (hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Nerve pain, carpal tunnel and ulnar tunnel symptoms, without a prior history of either conditions.
Pt was given ZOSTAVAX SC at 10 am 5/23/13. After vaccine pt stated burning at injection site. Rechecked pt after a few min, stated it was a little itchy. Observed pt for 15 min looked at injection site. No welt, swelling, and redness. Eval anaphylaxis. S/sx no problems w/ breathing, swelling, face or tongue. I explained to pt s/sx of anaphylaxis and what to watch for at site of injection. She said she felt fine and I told her she was free to go. Call with any problems throughout the day. Pt called me at 11:15 am stating she didn't know if she was having a reaction, but had a rash developing that you could see under magnification and the her tongue had 2 little bumps at the end of it. I asked if her breathing was ok - she needed to go to ER or primary MD office to be evaluated. She said she was fine to drive, didn't need to call 911. I called dr office to let them know I gave her the ZOSTAVAX vaccine, she had a rash starting and was coming in to be evaluated. I followed proper procedures and protocol. Pt was evaluated by dr - she came back to pharmacy with OTC meds and MD sent prednisone tapes for ADR to vaccine at 1:27 pm. I spoke with pt and told her I would check on her in a few days.
Blinding Headache, tingling & numb lips & mouth; received Benadryl, CAT Scan
This spontaneous report was received from a Pharmacist concerning a patient of unknown age and gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On 03-AUG-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot # R004689; expiration date: 29-NOV-2020) or (lot # R006689; expiration date: 29-NOV-2020) (dose and route of administration were not reported) for prophylaxis, which had a temperature excursion of 47°F to 77°F (56F) for 15 days on unspecified dates. There were no previous temperature excursions and no digital data logger involved in recording the temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Sender's Comments: US-009507513-1808USA012996: US-009507513-1809USA006252: US-009507513-1809USA006253: US-009507513-1809USA006254: US-009507513-1809USA006255: US-009507513-1809USA006256: US-009507513-1809USA006257: US-009507513-1809USA006258: US-009507513-1809USA006259: US-009507513-1809USA006260: US-009507513-1809USA006261: US-009507513-1809USA006262: US-009507513-1809USA006263.
Pt received vaccine and was seated.  I went back to pharmacy and realized the patient had fainted.  By the time I got to the patient he had regained consciousness.  I gave the patient 2 cold packs and told him to take off his mask.  I also gave him a bottle of water and a glucose tablet.
24hrs after vaccines were administered, patient developed redness over the (R) and (L) deltoid. Patient presented on 7/20/2017 with (R) deltoid- 2in x 31/2in circular erythema and (L) deltoid-21/2in x 13/4in circular erythema.
Received H1N1 Influenza Live Attenuated Nasal Spray. Two hours later developed shortness of breath, chest pressure, and anxiety. Nebulizer albuterol given 0.085-symptoms improved.
no adverse event; Expired dose of PROQUAD was administered to a 4 year old on 4/11/2022; This spontaneous report was received from a nurse and refers to a 4-years-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 11-APR-2022, the patient received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, lot # T034613, expiration date: 10-APR-2022, administered for prophylaxis (strength, dose number, dose, and route of administration were not provided) (expired product administered).   There were no other issues or concerns noted (no adverse event).
This spontaneous report as received from a nurse refers to a 62 year old male patient with allergy to oxycodone and PERCOCET. Pertinent medical history was not reported. On 19-SEP-2012, the patient was vaccinated with PNEUMOVAX 23 (dose, route and lot number were not reported). Concomitant medication was not reported. On 20-SEP-2012, the day after the vaccination, the patient experienced redness and warmth at injection site. The patient sought medical attention and was treated with KEFLEX for 7 days, an injection of dexamethasone and nonsteroidal anti-inflammatory drugs as needed. On an unknown date, the patient recovered from redness and warmth at injection site. Causality was not reported. Additional information has been requested.
devel swollen trachea-almost closed off; adm to ICU & rx w/steroids & antihistamines;discharged 20OCT  @ 8AM 23OCT 4AM hives;
p/vax pt devel skin lesions @ site of inj & lt shoulder;pt went to ER & was dx w/chickenpox & an ear infect;pt was prescribed amoxicillin for the ear infect;
After receiving Havrix and Boostrix immunizations patient started immediately experiencing nausea, light headed, sweating, tunnel vision, and voice sounding like in a tunnel (she experience this for about 20 minutes after the shot and then she felt okay).
patient reached out to pharmacy on 1-19-21 to report that her arm was sore and red all the way down to her elbow and "itchy".  she also stated that above her upper lip, was blisters and red, itchy, tender and swollen.  she report this started on the day after her vaccination. i asked her if she had run any fever to which she wasn't aware that she had.  i suggested the blisters on her lip could possibly be fever blisters but she reports to have never had them before.  she reports no other rash- just the arm of her injection and her lip.  i instructed her to take a benadryl and some tylenol and i will follow up with her tomorrow - she did report that  it does appear to be getting better as of today (tuesday)
ABOUT 1020 25 MINUTES AFTER VACCINE ADMINISTRATION PATIENT FELT ITCHY ALL OVER BODY.  PATIENT DESCRIBES ITCHING AS MODERATE.  NO RASH NOTED.  NO ANGIOEDEMA.  PATIENT NO IN RESPIRATORY DISTRESS. 1028 VITALS: BP: 172/93 P: 62 SAO2: 99%. BENADRYL 50MG ORAL GIVEN AT THIS TIME. 1038 VITALS: BP: 155/99 P: 64 SAO2: 99% PATIENT DESCIBES ITCHING AS THE SAME, MODERATE.  NO REDNESS AT SITE, NO RASH, NO RESPIRATORY DISTRESS. 1048 VITALS: BP: 164/108 P: 63 SAO2: 99% PATIENT TAKEN TO ER
Altered mental status, weakness, inability to ambulate, headache, fever, urine incontinence. Symptoms first noted 11/12/21  10am and progressively worsened over day.  Decreased alerntness, confusion and progressive weakness between 10am-6pm.  Family doctor was notified and we were informed to take her to emergency room.  Approxiamtely 1830 Called 911 since she was unable to ambulate and had AMS.    Workup at ER was done and patient discharged to home around 2330.   Lab work WNL, CXR WNL, Cardiac enzymes WNL, EKG abnormal (patient has AS, will have workup with cardiologist).  Patient had multiple incontinent episodes between 7pm and 3am, which is not baseline.     Patient was found to ambulate  3am when she was found walking to bathroom on own.    11/13/21 6pm patient reported to be at baseline physically, ambulating on own, performing baseline ADLs.  Patient complaints at that time HA and fatigue continued.  11/14/21--patient at baseline physically and mentally.  C/O HA and fatigue.
I noticed increasing episodes of SOB, dizziness, and PVCs.  My blood pressure continued to increase.   After 4 weeks of increasing  symptoms I reported to the ED.  I was admitted for Right Lower Lobe blood clot, hypertension, and PVCs.
pt recvd 1st dose of Engerix-B on 30NOV92; 8PM pt devel flu-like sx & diverticulum;
Adverse effects for both shots. Shot 1: April 1st @ 12:30PM. Lot ER8733. Sever pain on 5 spots on head and shoulder. Sever headache; fever, chills, nausea, red face that comes and goes. Symptoms lasted until April 13th.  Shot 2: April 22nd @ 8:05AM. Headache, nausea and fatigue began at 6:00PM on April 22nd. April 23rd through present: Severe fatigue; fever, chills, nausea, red face that comes and goes.
pt recv vax & devel rash on face & chest;RN noted blotchy red area on face, cheeks, chest & neck area;epi given;
Rash / samll rash presented on the left arm at injection site down to elbow and up to the neck/ bunch of spots on arm, neck shoulder; Rash / samll rash presented on the left arm at injection site down to elbow and up to the neck/ leg, torso; This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 78-year-old male patient who received Herpes zoster (Shingrix) (batch number 2AH5M, expiry date 18th May 2021) for prophylaxis.   Previously administered products included Shingrix (1st dose received on November 2018).   On 10th January 2019, the patient received the 2nd dose of Shingrix .5 ml. In April 2019, less than 4 months after receiving Shingrix, the patient experienced injection site rash and rash. The patient was treated with clobetasol propionate (Clobetasol) and prednisone. On an unknown date, the outcome of the injection site rash and rash were not recovered/not resolved.   It was unknown if the reporter considered the injection site rash and rash to be related to Shingrix.  Additional case details were reported as follows: The patient received vaccine in left arm. In April 2019, a small rash was presented on the left arm at injection site down to elbow and up to the neck.  It presented as eight or nine 1 and 2 inch circle spots.  It was treated with Clobetasol and resolved temporarily but presented again after treating. This continued in a cycle. At the end of June, early July the bunch of spots were on arm neck and expanded to the shoulder. The patient noted that these were areas that were exposed to sun. Toward middle of July the rash became more intense. The patient was treated with several cycles of prednisone. The rash would clear and then return 5 days after finishing the prednisone. The patient was on his 4th cycle of prednisone and each time it represented it was expanded to another area. It was currently on his legs and torso. The reporter consented to follow up.
Information has been received from a health professional concerning a male child who was vaccinated with 1 dose of varicella virus vaccine live. Subsequently, the patient experienced chickenpox. His body was covered with chickenpox. Another patient was reported with a similar experience. No further information is available.
Pt has numbness in the arm where flu shot was given. Close to 2 months and no improvement. Pt saw primary MD but referred to physical therapist.
Patient developed reddened, warm, swollen, tender area to left lower extremity the evening vaccines were given.  Presented to office 03/28/2006 to see doctor - diagnosed with Cellulitis and treated with Keflex for 10 days.
soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness, itchiness, redness and warmness in the injection site; soreness and swelling; soreness and swelling; This spontaneous case was reported by a patient and describes the occurrence of PAIN (soreness and swelling), SWELLING (soreness and swelling), VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included LEVOTHYROXINE and ANTACID for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN (soreness and swelling) and SWELLING (soreness and swelling). On 29-Mar-2021, the patient experienced VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE PAIN (soreness, itchiness, redness and warmness in the injection site). On 24-Mar-2021, PAIN (soreness and swelling) and SWELLING (soreness and swelling) had resolved. At the time of the report, VACCINATION SITE WARMTH (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE PRURITUS (soreness, itchiness, redness and warmness in the injection site), VACCINATION SITE ERYTHEMA (soreness, itchiness, redness and warmness in the injection site) and VACCINATION SITE PAIN (soreness, itchiness, redness and warmness in the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, Angiogram: inconclusive (Inconclusive) inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
Patient experienced localized reaction within 24 hours. Seen in MD office 48 hours after injection. Upper arm rash, red, swollen, hot; size approximately 6"x10". Cold compresses, Benadryl PRN and follow up 24 hours.
Patient came in and asked for immunization printout. He said he came in on a Friday night and got a flu shot here on 10/15/15. He said he has been sore in his arm ever since. He said he had not told that to anyone here at pharmacy until today. He said he read on internet this could be a problem of vaccine.
Bivalent vaccine inadvertently administered instead of monovalent vaccine. No abnormal signs/symptoms observed afterwards.
Moderate to severe seizure. Hadn?t had seizure for over 2 years, but the night of the booster had one that lasted 10-15 minutes, also causing severe muscle and head pain.
Patient states the next day after receiving vaccinations that he broke out in a rash that itched. Patient appeared with a rash below elbow on each arm.  Patient reported no allergies.  Patient reported no  redness  or  swelling  at the site  of  the  vaccinations.    Patient was advised to follow up wit his primary care physician It is possible patient may have received previous vaccinations from another facility not recorded.
19 year old male presents with chest pain.  Patient had his second Pfizer vaccine on July 16 and starting next day had a headache and some body aches with some shortness of breath.  The headache and body aches resolved by the next day but he has had persistent shortness of breath especially dyspnea with exertion.  Is also described intermittent chest pain across his chest.  He has had no fevers no coughs no palpitations.  He does get some increased heart rate with exertion.  He has had no rash no leg pain.   He was seen by his pediatrician who ordered a troponin, sed rate CRP and D-dimer and EKG.  The inflammatory markers and troponin are normal, the EKG shows a normal sinus rhythm normal axis normal intervals.  However the D-dimer is elevated raising potential concern for pulmonary embolus. ED course: Patient overall appears well.  His history is concerning for possible pulmonary embolus, however this is not a reported known side effect with the Pfizer vaccine.  He does not have evidence of myocarditis or pericarditis on exam or via the laboratory tests or EKG.  We will repeat the D-dimer to make sure that the other result was not spurious and check a CBC.  If the D-dimer is elevated we will check a CTA.  Will discuss with pulmonary.   D-dimer continued to be elevated. CTA does not show evidence of a PE. Pt feels better, I have discussed w pulmonary and they will arrange for f/u within 1-2 weeks. Information with the vaccine symptom tracking system will be filed.            Patient safe for discharge to home. Discharged in improved condition. Written instructions reviewed with family.
Very mild soreness at injection site.  Pain = 1 on scale of 1 to 10.  This report is being filed because the patient denied having had a tetanus vaccine in 14 years and did not report receiving a T-DAP vaccine in January of 2008. This record was discovered after administration of vaccine on July 8, 2008. ("onset" is date of discovery)
Headache started, thought is was cold front drove thru.  HIGH BP. 166/105  P 60 @ 4:38 PM. Went higher to 195/98 P 66 over next several hours.  Thursday, still high 185/99 p 69 @ 9:58 am.  Went to ER because headache was getting worse. ER doctor prescribed Norvasc 2.5 ....Next day Friday, BP still high, even with BP meds went back to ER, took CT Scan of Head, EKG and blood work. all came out normal. told to be continue with BP Norvasc and follow up with GP doctor.   Saturday (today) BP still high 174/90 p 68.
Since onset, the problem has been gradually worsening. Affected locations: Entire body, started on face neck and chest, has spread to entire body. Associated symptoms include sore throat, malaise, fatigue, non-blanching rash, fever, and myalgias. Negative for cough, congestion, shortness of breath, vomiting, nail changes, joint pain, facial edema, painful lesions, rhinorrhea, headache, and diarrhea. Symptoms are relieved by OTC analgesics/fever reducers. Associated symptoms include chills, arthalgia (2 days ago for a few days), and fever (tactile, felt chilled). Negative for ear pain (Reports she got dizzy for a few minutes on Friday (2 days ago) right top gums hurts, reports bleeding when she brushes her teeth. Right side of throat started hurting this morning). Risk factors include Negative for sick contacts. PMH significant for Negative for tuberculosis, cancer, immunocompromised, renal insufficiency, liver disease, and HIV.
temp of 102, all lymph nodes in neck swollen seen by MD-APAP as treatment;
2 days Later arm was still red at site of injection and became itchy. Itchiness continued for a week and a half. 4 weeeks later my arm injection site is still red and slightly darker in color .
Patient had capacity and stated that he had not received any previous Covid vaccines. In reviewing the Immunization Registry, he had not received any previous Covid vaccines. We set him up to receive the J&J Covid vaccine today. When his wife got here prior to discharge, she indicated that he had received a Pfizer vaccine before at a skilled nursing facility. She was made aware that he did receive J&J today and was fine with that.   In reviewing his chart, he was at Nursing Facility. I called and spoke with their nurse and she indicated that patient had actually received the Moderna vaccine on 2/07/21. I inquired if they are inputting this into the registry and she stated that they were having Pharmacy input all of them. I did inform her that this one wasn?t input into the registry and that he did receive the J&J vaccine today. She stated that she would follow up with her director.  At this time, patient has had no adverse reactions to receiving both vaccines.
Vaccine given Lt. deltoid-after approx 7 minutes she commented that she could taste the vaccine-5 minutes later said her tongue felt fuzzy-checked no enlargement-no other symptoms.
gbs; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced guillain barre syndrome (serious criteria hospitalization, GSK medically significant and life threatening). On an unknown date, the outcome of the guillain barre syndrome was unknown.   It was unknown if the reporter considered the guillain barre syndrome to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The reporter was reported for himself/herself. In 2004, the patient got guillain barre syndrome in 2004 and stayed in hospital for 5 and half months. The reporter stated that, the lord spread his/her life after going on ventilator for 2 weeks.
I felt super hot within an hour of the vaccine. Developed large rash, Extremely swelling in the left arm. Prescribed Prednisone
The booster shot was given too early.  It was not due until after March 16, 2022.
received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 48-year-old patient who received DTPa (Reduced antigen) (Tdap Vaccine) (batch number YR7AA) for prophylaxis.   On 13-JAN-2023, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR061580:same reporter US-GSK-US2023AMR062067:same reporter US-GSK-US2023AMR061582:same reporter US-GSK-US2023AMR061583:same reporter US-GSK-US2023AMR061581:same reporter US-GSK-US2023AMR062059:same reporter US-GSK-US2023AMR062065:same reporter US-GSK-US2023AMR062063:same reporter US-GSK-US2023AMR063143:Same reporter US-GSK-US2023AMR063144:Same reporter US-GSK-US2023AMR063146:Same reporter US-GSK-US2023AMR063147:Same reporter US-GSK-US2023AMR063148:Same reporter US-GSK-US2023AMR063149:Same reporter